Cerebral Blood Flow and Oxygen Metabolism Measurements Using Positron Emission Tomography on the First Day after Carotid Artery Stenting

Author(s):  
Nobuyuki Kawai ◽  
Tetsuhiro Hatakeyama ◽  
Masanobu Okauchi ◽  
Masahiko Kawanishi ◽  
Atsushi Shindo ◽  
...  
2012 ◽  
Vol 18 (3) ◽  
pp. 264-274 ◽  
Author(s):  
N. Kawai ◽  
M. Kawanishi ◽  
A. Shindou ◽  
N. Kudomi ◽  
Y. Yamamoto ◽  
...  

Balloon test occlusion (BTO) of the internal carotid artery (ICA) combined with cerebral blood flow (CBF) study is a sensitive test for predicting the outcome of permanent ICA occlusion. However, false negative results sometimes occur using single photon emission tomography (SPECT). We have recently developed a rapid positron emission tomography (PET) protocol that measures not only the CBF but also the cerebral oxygen metabolism before and during BTO in succession. We measured acute changes in regional CBF and OEF/CMRO2 before and during BTO in three cases with large or giant cerebral aneurysms using the rapid PET protocol. Although no patients showed ischemic symptoms during BTO, PET studies exhibited mildly to moderately decreased CBF (9∼34%) compared to the values obtained before BTO in all cases. The average OEF during BTO was significantly increased (21% and 43%) than that of before BTO in two cases. The two cases were considered to be non-tolerant for permanent ICA occlusion and treated without ICA sacrifice. Measurement of the CBF and OEF/CMRO2 using a rapid PET protocol before and during BTO is feasible and can be used for accurate assessment of tolerance prediction in ICA occlusion.


1998 ◽  
Vol 4 (1) ◽  
pp. 57-62 ◽  
Author(s):  
K.J. Murphy ◽  
J.P. Deveikis ◽  
J.A. Brunberg ◽  
D.A. Jamadar ◽  
K.A. Frey

The purpose of this paper was to evaluate the effects of acetazolamide on cerebral blood flow (CBF) measured by [O-15] H2O positron emission tomography (PET) during balloon test occlusion (BTO) of the internal carotid artery (ICA). [O-15] H2O PET cerebral blood flow studies were completed in 20 patients undergoing BTO. CBF determinations were obtained without carotid occlusion as a baseline, following balloon occlusion, and as a third scan with balloon occlusion after an intravenous acetazolamide bolus. The balloon was left deflated between scans, and was only inflated immediately before and during the 90 second period of time needed for CBF determination. Significance was determined at the P<0.05 level. Two of twenty studies were technical failures. Prior to acetazolamide there was a significant decrease in CBF (P<0.0007) ipsilateral to the occlusion. After acetazolamide administration there was no statistically significant change in flow on the occluded side (P<0.3047); however, there was a significant increase in cerebral blood flow (P<0.0002) on the non-occluded side. In this patient population, there was no acetazolamide-induced CBF decompensation (steal) phenomenon or haemodynamically significant risk in CBF ipsilateral to the occlusion.


Sign in / Sign up

Export Citation Format

Share Document